3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Stomach Neoplasms
2
Oropharyngeal Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Retinoblastoma
1
Recurrence
1
Rectal Neoplasms
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Osteoporosis
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Interventions
Fluorouracil
37
Radiotherapy
31
Oxaliplatin
29
Cisplatin
28
Paclitaxel
24
Leucovorin
22
Irinotecan
19
Docetaxel
13
pembrolizumab
10
Capecitabine
10
Carboplatin
9
Radiation
8
Neoadjuvant Therapy
8
Cetuximab
8
Surgical Procedures, Operative
7
Folfox protocol
7
Chemotherapy, Adjuvant
6
Nivolumab
5
Gefitinib
5
Taxes
4
Erlotinib Hydrochloride
4
Biopsy
4
durvalumab
3
Panitumumab
3
Itraconazole
3
Epirubicin
3
Bevacizumab
3
tremelimumab
2
spartalizumab
2
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Adenocarcinoma Of Esophagus
×
Observation
×
Clear all
NCT06933966
2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2
Not yet recruiting
120 enrolled